PepGen Inc.

The momentum for this stock is not very good. PepGen Inc. is not a good value stock. PepGen Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in PepGen Inc..
Log in to see more information.
PEPG Fundamental Data by TradingView

News

PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & Development
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & Development

Business Wire PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and...\n more…

PepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & Development
PepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & Development

Business Wire PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and...\n more…

PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Globe Newswire NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PepGen Inc. ( PepGen or the...\n more…

PepGen (NASDAQ:PEPG) and Bicycle Therapeutics (NASDAQ:BCYC) Head to Head Survey
PepGen (NASDAQ:PEPG) and Bicycle Therapeutics (NASDAQ:BCYC) Head to Head Survey

Zolmax PepGen (NASDAQ:PEPG - Get Free Report) and Bicycle Therapeutics (NASDAQ:BCYC - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two...\n more…

Wedbush Weighs in on PepGen Inc.'s Q3 2024 Earnings (NASDAQ:PEPG)
Wedbush Weighs in on PepGen Inc.'s Q3 2024 Earnings (NASDAQ:PEPG)

Ticker Report PepGen Inc. (NASDAQ:PEPG - Free Report) - Research analysts at Wedbush reduced their Q3 2024 earnings estimates for PepGen in a research note issued to investors on Thursday, August 8th. Wedbush...\n more…

PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Business Wire Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PepGen Inc. (PepGen or the Company) (NASDAQ: PEPG). Investors who purchased...\n more…